Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination

We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the pos...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy and pharmacology Vol. 67; no. 3; p. 409
Main Authors McCrudden, Maelíosa T C, Torrisi, Barbara M, Al-Zahrani, Sharifah, McCrudden, Cian M, Zaric, Marija, Scott, Christopher J, Kissenpfennig, Adrien, McCarthy, Helen O, Donnelly, Ryan F
Format Journal Article
LanguageEnglish
Published England 01.03.2015
Subjects
Online AccessGet more information

Cover

Loading…
Abstract We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the possibility of using minimally invasive MN technologies to replace conventional hypodermic vaccine injections. The focus of this study was exploitation of dissolving MN array devices fabricated from 20% w/w poly(methyl vinyl ether/maleic acid) using a micromoulding technique, for the facilitated delivery of a model antigen, ovalbumin (OVA). A series of in-vitro and in-vivo experiments were designed to demonstrate that MN arrays loaded with OVA penetrated the stratum corneum and delivered their payload systemically. The latter was evidenced by the activation of both humoral and cellular inflammatory responses in mice, indicated by the production of immunoglobulins (IgG, IgG1, IgG2a) and inflammatory cytokines, specifically interferon-gamma and interleukin-4. Importantly, the structural integrity of the OVA following incorporation into the MN arrays was maintained. While enhanced manufacturing strategies are required to improve delivery efficiency and reduce waste, dissolving MN are a promising candidate for 'reduced-risk' vaccination and protein delivery strategies.
AbstractList We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the possibility of using minimally invasive MN technologies to replace conventional hypodermic vaccine injections. The focus of this study was exploitation of dissolving MN array devices fabricated from 20% w/w poly(methyl vinyl ether/maleic acid) using a micromoulding technique, for the facilitated delivery of a model antigen, ovalbumin (OVA). A series of in-vitro and in-vivo experiments were designed to demonstrate that MN arrays loaded with OVA penetrated the stratum corneum and delivered their payload systemically. The latter was evidenced by the activation of both humoral and cellular inflammatory responses in mice, indicated by the production of immunoglobulins (IgG, IgG1, IgG2a) and inflammatory cytokines, specifically interferon-gamma and interleukin-4. Importantly, the structural integrity of the OVA following incorporation into the MN arrays was maintained. While enhanced manufacturing strategies are required to improve delivery efficiency and reduce waste, dissolving MN are a promising candidate for 'reduced-risk' vaccination and protein delivery strategies.
Author Zaric, Marija
Scott, Christopher J
Torrisi, Barbara M
Al-Zahrani, Sharifah
McCrudden, Cian M
McCrudden, Maelíosa T C
McCarthy, Helen O
Donnelly, Ryan F
Kissenpfennig, Adrien
Author_xml – sequence: 1
  givenname: Maelíosa T C
  surname: McCrudden
  fullname: McCrudden, Maelíosa T C
  organization: School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, UK
– sequence: 2
  givenname: Barbara M
  surname: Torrisi
  fullname: Torrisi, Barbara M
– sequence: 3
  givenname: Sharifah
  surname: Al-Zahrani
  fullname: Al-Zahrani, Sharifah
– sequence: 4
  givenname: Cian M
  surname: McCrudden
  fullname: McCrudden, Cian M
– sequence: 5
  givenname: Marija
  surname: Zaric
  fullname: Zaric, Marija
– sequence: 6
  givenname: Christopher J
  surname: Scott
  fullname: Scott, Christopher J
– sequence: 7
  givenname: Adrien
  surname: Kissenpfennig
  fullname: Kissenpfennig, Adrien
– sequence: 8
  givenname: Helen O
  surname: McCarthy
  fullname: McCarthy, Helen O
– sequence: 9
  givenname: Ryan F
  surname: Donnelly
  fullname: Donnelly, Ryan F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24673568$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKw0AYhQdR7EU3PoDMC6TOPRN3UqwKBTe6Ln9m_rRTkkmYiYW-vcHL2Rw4H3xwFuQy9hEJueNsxac8HIfDsOJCKHtB5oIpUZRc2xlZ5HxkjJXGmGsyE8qUUhs7J3kLGVOBcR8iYkJPfci5b08h7mkXXJr06FukkBKcM236RIfUjxgi9diGE6bzIx2mIY4B2h-O8QDRTaoQxwQeUzeBEzgXIoyhjzfkqoE24-1fL8nn5vlj_Vps31_e1k_bwhkhbKErKBvXSKyNtaoUTIKECidkjZPeCq54KSsuHGNOKSN1pcDUtRIlaK1RLMn9r3f4qjv0uyGFDtJ59_9efAPGKl2A
CitedBy_id crossref_primary_10_1088_1361_6528_ace97b
crossref_primary_10_1128_AAC_02612_18
crossref_primary_10_1016_j_nano_2016_11_019
crossref_primary_10_1080_17425247_2018_1505860
crossref_primary_10_1007_s11095_017_2223_2
crossref_primary_10_1007_s13346_015_0252_0
crossref_primary_10_1016_j_jconrel_2019_11_023
crossref_primary_10_3390_pharmaceutics12060569
crossref_primary_10_1007_s13346_022_01190_x
crossref_primary_10_1007_s13770_023_00527_y
crossref_primary_10_1080_17425247_2021_1823964
crossref_primary_10_1016_j_addr_2021_06_002
crossref_primary_10_1016_j_apsb_2021_03_003
crossref_primary_10_1021_acs_molpharmaceut_8b00895
crossref_primary_10_3389_fvets_2022_891286
crossref_primary_10_1517_17425247_2016_1115835
crossref_primary_10_1016_j_ijpharm_2018_07_049
crossref_primary_10_1016_j_jconrel_2017_07_032
crossref_primary_10_3390_catal7010004
crossref_primary_10_1116_1_4960715
crossref_primary_10_1038_s41598_018_30290_3
crossref_primary_10_1016_j_ijpharm_2019_05_066
crossref_primary_10_1021_acsbiomaterials_9b00961
crossref_primary_10_1016_j_biomaterials_2020_120410
crossref_primary_10_1016_j_isci_2022_105045
crossref_primary_10_1080_17425247_2018_1522301
crossref_primary_10_3390_vaccines7040159
ContentType Journal Article
Copyright 2014 Royal Pharmaceutical Society.
Copyright_xml – notice: 2014 Royal Pharmaceutical Society.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1111/jphp.12248
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2042-7158
ExternalDocumentID 24673568
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/K020234/1
– fundername: Wellcome Trust
  grantid: WT094085MA
– fundername: Wellcome Trust
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/E020534/1
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/FOF/287
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29L
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
52M
52O
52S
52T
52U
52V
52W
53G
5GY
5RE
5WD
702
7PT
8-0
8-1
8-3
8-4
8-5
8WZ
930
A01
A03
A6W
AABZA
AACZT
AAESR
AAEVG
AAHHS
AAONW
AAPGJ
AAPXW
AARHZ
AAUAY
AAVAP
AAWDT
AAYOK
AAZKR
ABCUV
ABJNI
ABLJU
ABNHQ
ABOCM
ABPQP
ABPTD
ABPVW
ABQNK
ABWST
ABXVV
ACBWZ
ACCFJ
ACFBH
ACFRR
ACGFO
ACGFS
ACIWK
ACMXC
ACPOU
ACPRK
ACUTJ
ACXQS
ACYHN
ACZBC
ADBBV
ADEOM
ADIPN
ADIZJ
ADKYN
ADMGS
ADQBN
ADVEK
ADXAS
ADZMN
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFFZL
AFGKR
AFPWT
AFRAH
AFXAL
AFYAG
AFZJQ
AGMDO
AGQXC
AGUTN
AHMBA
AI.
AIAGR
AIURR
AIWBW
AJAOE
AJBDE
AJEEA
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
AMYDB
APJGH
AQDSO
ASPBG
ATGXG
ATUGU
AVNTJ
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCRHZ
BDRZF
BEYMZ
BHBCM
BROTX
BRXPI
C45
CAG
CGR
COF
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
DU5
EBS
ECM
EIF
EJD
EMOBN
F00
F01
F04
F5P
FECEO
FEDTE
FLUFQ
FOEOM
G-S
G.N
GODZA
H.X
H13
HF~
HVGLF
HZ~
KBUDW
KOP
KSI
KSN
L7B
LATKE
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
NNB
NOMLY
NPM
O66
O9-
OAUYM
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4D
PALCI
PQQKQ
Q.N
QB0
R.K
RIWAO
RJQFR
ROL
ROX
RX1
SUPJJ
TEORI
TMA
UB1
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
X7M
XG1
YCJ
ZGI
ZXP
ZZTAW
~IA
~WT
ID FETCH-LOGICAL-c6228-59a7fcf3eb68847203a3a9e22886c3d8214173912c00c4463594a6bb427a555e2
IngestDate Wed Oct 16 00:44:48 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords microneedles
laser-engineering
protein delivery
vaccination
Language English
License 2014 Royal Pharmaceutical Society.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c6228-59a7fcf3eb68847203a3a9e22886c3d8214173912c00c4463594a6bb427a555e2
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938851
PMID 24673568
ParticipantIDs pubmed_primary_24673568
PublicationCentury 2000
PublicationDate March 2015
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: March 2015
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of pharmacy and pharmacology
PublicationTitleAlternate J Pharm Pharmacol
PublicationYear 2015
SSID ssj0007666
Score 2.3127935
Snippet We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains...
SourceID pubmed
SourceType Index Database
StartPage 409
SubjectTerms Administration, Cutaneous
Animals
Antigens - administration & dosage
Drug Delivery Systems
Interferon-gamma - blood
Interleukin-4 - blood
Lasers
Maleates - chemistry
Methyl Ethers - chemistry
Mice
Microinjections
Needles
Ovalbumin - administration & dosage
Polyvinyls - chemistry
Skin - metabolism
Skin Absorption
Solubility
Vaccination - methods
Vaccines - administration & dosage
Title Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination
URI https://www.ncbi.nlm.nih.gov/pubmed/24673568
Volume 67
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBWb9NJL6fdHmqJDycXxYsuWbPUWti2hdEMOGwi9BFmWWIPjGO-mkPy1_LmOJHutbhtIezFG4zVG7-1oNBo9IfSRwZBQciVCpuHvlvJChLxkDKYqMtIFp2Vij-mcn7Djs_TbOT2fTO68qqXrdTGVt3_dV_I_qEIb4Gp2yf4DspuXQgPcA75wBYTh-iCMv8MQ1IWqlxSE0NGsrl_VNkdwaSrtoLmsVSC6TtxY4YXA6jLYCtjaVGRYvacWmpp15bYyBqpZuqqAyuR9S-O56-CnkLJqRhT_DGdbp4Ht5JzaURB7rDKWs-56cHNzoWq7Rv_5aiWCReBluztwO5W3FDLma4_q8IdYdu4UKis1Xekxnf3b-2fGb839lEZMx5quqbKuj5hNQ1nsRN0HP-2O7ej5mHhON7UCC_cOBu2ynZr1w9x_CHq3vbS0IDBUJJQ9wLolzD2YdtBOlptTQ05MoqgPAjKYFvZquLZwbPMRRn26_-HWTMZGNIun6EmPHT5yvHqGJqp5jg5OexwP8WLcmrc6xAf41AP1BVptkw-P5MMe-bAjHwZq4Z58eCDfJ7yhnrUP1MMe9bBHvZfo7OuXxew47E_wCCUjJA8pF5mWOlEFyyEMIlEiEsEVmHImkzIncRpnCY-JjCKZphD88lSwokhJJiilirxCuw187huEtdC8VIoWXMCDmuZFwnIVSa1jDbf0LXrtOvOidTItF0M3v7vXsocej_R7jx5p8AtqH4LMdfHBwvkLHUyEag
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Laser-engineered+dissolving+microneedle+arrays+for+protein+delivery%3A+potential+for+enhanced+intradermal+vaccination&rft.jtitle=Journal+of+pharmacy+and+pharmacology&rft.au=McCrudden%2C+Mael%C3%ADosa+T+C&rft.au=Torrisi%2C+Barbara+M&rft.au=Al-Zahrani%2C+Sharifah&rft.au=McCrudden%2C+Cian+M&rft.date=2015-03-01&rft.eissn=2042-7158&rft.volume=67&rft.issue=3&rft.spage=409&rft_id=info:doi/10.1111%2Fjphp.12248&rft_id=info%3Apmid%2F24673568&rft_id=info%3Apmid%2F24673568&rft.externalDocID=24673568